News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

While a phase III study did not find a significant improvement in overall survival of Asian patients with advanced #StomachCancer treated with olaparib, the data collected will provide initial information for further studies.

Read Source
X